idiopathic Castleman disease
Showing 1 - 25 of >10,000
ProducingNovel Symptom Burden Scale for People Living With
Not yet recruiting
- Idiopathic Multicentric Castleman's Disease
- Research questions
- (no location specified)
Aug 17, 2023
Castleman Disease, Castleman's Disease, Multicentric Trial in Little Rock, La Jolla, Philadelphia (Sirolimus)
Recruiting
- Castleman Disease
- Castleman's Disease, Multicentric
-
Little Rock, Arkansas
- +3 more
Jan 6, 2023
Idiopathic Multicentric Castleman's Disease Trial in Beijing, Chengdu (Recombinant Humanized Anti-interleukin-6 Receptor
Recruiting
- Idiopathic Multicentric Castleman's Disease
- Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 4mg/kg
- +2 more
-
Beijing, China
- +2 more
Apr 26, 2022
Idiopathic Multicentric Castleman's Disease Trial in Lansing (Siltuximab)
Terminated
- Idiopathic Multicentric Castleman's Disease
-
Lansing, MichiganEdward W. Sparrow Hospital
Apr 15, 2021
Castleman Disease, Castleman's Disease, Giant Lymph Node Hyperplasia Trial in Worldwide
Recruiting
- Castleman Disease
- +8 more
-
Philadelphia, Pennsylvania
- +9 more
Dec 5, 2022
Idiopathic Multicentric Castleman's Disease Trial in Beijing (Zanubrutinib)
Recruiting
- Idiopathic Multicentric Castleman's Disease
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Feb 5, 2021
Unicentric Form of Castleman Disease - Surgery Therapy Benefit
Completed
- Castleman Disease
- +2 more
- surgery type/exstirpation/debulking
- (no location specified)
Jun 28, 2022
KSHV Inflammatory Cytokine Syndrome (KICS), Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease Trial run by
Not yet recruiting
- KSHV Inflammatory Cytokine Syndrome (KICS)
- Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 2, 2023
Castleman's Disease (CD), Langerhans Cell Histiocytosis (LCH), Non-Langerhans-Cell Histiocytosis Trial in Cleveland (Genetic
Recruiting
- Castleman's Disease (CD)
- +2 more
- Genetic testing
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
Jun 21, 2022
Lymphoproliferative Disorder, HHV-8, Malignancy Trial run by the National Cancer Institute (NCI) (Etoposide, Interferon-alpha,
Active, not recruiting
- Lymphoproliferative Disorder
- +3 more
- Etoposide
- +13 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
s From HIV Infection, KSHV Infection, Viral-Related
Recruiting
- HIV
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Collecting Blood and Tissue Sample Donations for Research for
Not yet recruiting
- Anal Carcinoma
- +11 more
- Biospecimen Collection
- (no location specified)
Dec 21, 2022
Fibrinogen to Albumin Ratio and C-reactive Protein to Albumin
Not yet recruiting
- Juvenile Idiopathic Arthritis
- fibrinogen to albumin ratio (AFR) and C-reactive protein to albumin ratio (CAR)
- (no location specified)
Aug 29, 2023
Burkitt Lymphoma, KSHV-associated Multicentric Castleman Disease, DLBCL Trial in Kampala (Rituximab and Hyaluronidase Human,
Recruiting
- Burkitt Lymphoma
- +2 more
- Rituximab and Hyaluronidase Human
- +8 more
-
Kampala, UgandaUCI-Fred Hutch Cancer Centre
Mar 9, 2022
Inflammatory Myopathy, Cardiac Disease Trial
Not yet recruiting
- Inflammatory Myopathy
- Cardiac Disease
- (no location specified)
Aug 4, 2023
Idiopathic Parkinson's Progression and Dopamine Transporter
Completed
- Parkinson Disease
- Ioflupane I 123
-
Lexington, KentuckyUniversity of Kentucky Department of Neurology
Nov 16, 2022
Parkinson Disease, Treatment Adherence Trial in Ankara (Levodopa)
Enrolling by invitation
- Parkinson Disease
- Treatment Adherence
-
Ankara, TurkeyAnkara Atatürk Sanatorium Training and Research Hospital
Oct 30, 2023
Idiopathic Pulmonary Fibrosis, Systemic Sclerosis With Lung Involvement Trial in El Paso (Vixarelimab, Placebo)
Recruiting
- Idiopathic Pulmonary Fibrosis
- Systemic Sclerosis With Lung Involvement
- Vixarelimab
- Placebo
-
El Paso, TexasEl Paso Pulmonary Association Elligo PPDS
Mar 14, 2023
Psychiatric Co-morbidities and Socio-demographic Characteristics
Recruiting
- Idiopathic Hypersomnia
- +2 more
- respond to questionnaires by telephone
-
Toulouse, FranceChu Toulouse
Mar 9, 2023
A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH
Recruiting
- Multiple Myeloma
- +11 more
- No intervention
-
Beijing, ChinaPeking University First Hospital
Apr 21, 2022
Idiopathic Parkinson's Disease Trial in Shanghai (hAESCs)
Not yet recruiting
- Idiopathic Parkinson's Disease
- hAESCs
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Jan 28, 2023
Parkinson Disease Trial (NeuraLight)
Not yet recruiting
- Parkinson Disease
- NeuraLight
- (no location specified)
May 17, 2023
Parkinson Disease Trial (NeuraLight)
Not yet recruiting
- Parkinson Disease
- NeuraLight
- (no location specified)
Mar 29, 2023
Fabry Disease in Portuguese Idiopathic Cardiomyopathies
Recruiting
- Fabry Disease
- Alfa-galactosidase activity and genetic testing for Fabry diagnosis
-
Porto, PortugalCentro Hospitalar Universitário São João
Jan 12, 2023